| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
| 1 | African trypanosomiasis 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 2 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 3 | Alzheimer disease 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 4 | Amoebiasis 3 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 5 | Antifolate resistance 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 6 | C-type lectin receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 7 | Cellular senescence 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: IL1A |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 8 | Chagas disease (American trypanosomiasis) 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 9 | Cytokine-cytokine receptor interaction 5 genes, 4 drugs (DrugBank) and 28 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 10 | Cytosolic DNA-sensing pathway 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 11 | EGFR tyrosine kinase inhibitor resistance 1 gene, 1 drug (DrugBank) and 16 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 12 | Fluid shear stress and atherosclerosis 4 genes, 3 drugs (DrugBank) and 21 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 13 | Gap junction 9 genes, 1 drug (DrugBank) and 5 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00570 |
Colchicine |
5件: 2, 42, 56, 93, 266 |
| 14 | Graft-versus-host disease 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 15 | Hematopoietic cell lineage 5 genes, 4 drugs (DrugBank) and 28 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 16 | Herpes simplex virus 1 infection 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 17 | HIF-1 signaling pathway 1 gene, 1 drug (DrugBank) and 16 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 18 | Human cytomegalovirus infection 3 genes, 4 drugs (DrugBank) and 28 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 19 | Human T-cell leukemia virus 1 infection 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 20 | IL-17 signaling pathway 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 21 | Inflammatory bowel disease (IBD) 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 22 | Inflammatory mediator regulation of TRP channels 2 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 23 | Influenza A 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 24 | JAK-STAT signaling pathway 1 gene, 1 drug (DrugBank) and 16 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 25 | Legionellosis 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 26 | Leishmaniasis 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 27 | Malaria 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 28 | MAPK signaling pathway 3 genes, 3 drugs (DrugBank) and 21 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 29 | Measles 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 30 | Necroptosis 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 31 | NF-kappa B signaling pathway 2 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 32 | NOD-like receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 33 | Non-alcoholic fatty liver disease (NAFLD) 3 genes, 3 drugs (DrugBank) and 22 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 34 | Osteoclast differentiation 3 genes, 3 drugs (DrugBank) and 21 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 35 | Pathogenic Escherichia coli infection 11 genes, 4 drugs (DrugBank) and 23 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00570 |
Colchicine |
5件: 2, 42, 56, 93, 266 |
| 36 | Pathways in cancer 1 gene, 1 drug (DrugBank) and 16 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 37 | Pertussis 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 38 | Phagosome 9 genes, 1 drug (DrugBank) and 5 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00570 |
Colchicine |
5件: 2, 42, 56, 93, 266 |
| 39 | PI3K-Akt signaling pathway 1 gene, 1 drug (DrugBank) and 16 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 40 | Prion diseases 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 41 | Prostate cancer 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 42 | Rheumatoid arthritis 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 43 | Salmonella infection 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 44 | Shigellosis 2 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 45 | Th17 cell differentiation 3 genes, 4 drugs (DrugBank) and 28 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 46 | TNF signaling pathway 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 47 | Toll-like receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 48 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 49 | Tuberculosis 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 50 | Type I diabetes mellitus 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: IL1A, IL1B |
D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 51 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 1 drug (DrugBank) and 16 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 52 | Yersinia infection 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
4件: 51, 106, 107, 266 |